Now is the time to invest in energy stocks, not trade them. Dan Dicker, Senior Energy Analyst at TheStreet tells Jill Malandrino that while certain energy stocks look good for long-term holds, there is still a lot of ground to make up. The key is looking for companies that have properly managed long-term oil prices versus using financial engineering tricks to try to stay alive with crude below $50. Dicker says one of the worst companies is Halcon Resources (HK) as it bought back bonds, but in a very mercenary way by making bondholders take a haircut on prices and take bad stock in lieu of debt in an effort to survive as a company a little bit longer. Even with HK trading at around $1, Dicker would not go near it as the bond restructuring further dilutes the common stock. Other companies that fall under this category include Sandridge Energy (SD) and Goodrich Petroleum (GDP). One of Dicker’s favorite long-term energy plays is EOG Resources (EOG) because the company has acreage that will last for decades and can continue delivering results in shale. Many of the marginal players are dealing with minimal amounts of acreage and once they start to run dry there will be nothing fresh to drill. EOG also has a tremendous portfolio of assets. Hess (HES) is another stock to own for 2016.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.